316 related articles for article (PubMed ID: 25694157)
1. The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations.
Heinberg A; Kirkman L
Ann N Y Acad Sci; 2015 Apr; 1342(1):10-8. PubMed ID: 25694157
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of resistance of malaria parasites to antifolates.
Gregson A; Plowe CV
Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
[TBL] [Abstract][Full Text] [Related]
3. Molecular assays for surveillance of antifolate-resistant malaria.
Kublin JG; Witzig RS; Shankar AH; Zurita JQ; Gilman RH; Guarda JA; Cortese JF; Plowe CV
Lancet; 1998 May; 351(9116):1629-30. PubMed ID: 9620719
[No Abstract] [Full Text] [Related]
4. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
[TBL] [Abstract][Full Text] [Related]
5. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
[TBL] [Abstract][Full Text] [Related]
6. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
[TBL] [Abstract][Full Text] [Related]
7. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
Biswas S
J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
[TBL] [Abstract][Full Text] [Related]
8. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.
Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE
Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635
[TBL] [Abstract][Full Text] [Related]
9. Basis for antifolate action and resistance in malaria.
Yuthavong Y
Microbes Infect; 2002 Feb; 4(2):175-82. PubMed ID: 11880049
[TBL] [Abstract][Full Text] [Related]
10. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
[TBL] [Abstract][Full Text] [Related]
11. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
[TBL] [Abstract][Full Text] [Related]
12. Adaptive copy number evolution in malaria parasites.
Nair S; Miller B; Barends M; Jaidee A; Patel J; Mayxay M; Newton P; Nosten F; Ferdig MT; Anderson TJ
PLoS Genet; 2008 Oct; 4(10):e1000243. PubMed ID: 18974876
[TBL] [Abstract][Full Text] [Related]
13. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.
Khan B; Omar S; Kanyara JN; Warren-Perry M; Nyalwidhe J; Peterson DS; Wellems T; Kaniaru S; Gitonga J; Mulaa FJ; Koech DK
Trans R Soc Trop Med Hyg; 1997; 91(4):456-60. PubMed ID: 9373654
[TBL] [Abstract][Full Text] [Related]
14. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase.
Sirawaraporn W; Sathitkul T; Sirawaraporn R; Yuthavong Y; Santi DV
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1124-9. PubMed ID: 9037017
[TBL] [Abstract][Full Text] [Related]
15. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
Cortese JF; Plowe CV
Mol Biochem Parasitol; 1998 Aug; 94(2):205-14. PubMed ID: 9747971
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
17. Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.
Tipsuwan W; Srichairatanakool S; Kamchonwongpaisan S; Yuthavong Y; Uthaipibull C
Malar J; 2011 May; 10():119. PubMed ID: 21554743
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study.
Biswas S
Indian J Malariol; 2001; 38(3-4):76-83. PubMed ID: 12125519
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance and genetic diversity of Plasmodium falciparum parasites from suriname.
Peek R; VAN Gool T; Panchoe D; Greve S; Bus E; Resida L
Am J Trop Med Hyg; 2005 Nov; 73(5):833-8. PubMed ID: 16282289
[TBL] [Abstract][Full Text] [Related]
20. Direct evidence for the adaptive role of copy number variation on antifolate susceptibility in Plasmodium falciparum.
Heinberg A; Siu E; Stern C; Lawrence EA; Ferdig MT; Deitsch KW; Kirkman LA
Mol Microbiol; 2013 May; 88(4):702-12. PubMed ID: 23347134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
